• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于从细胞培养物中纯化口疮病毒(Orf virus)以将其用作疫苗或病毒载体的色谱方法选择。

Selection of chromatographic methods for the purification of cell culture-derived Orf virus for its application as a vaccine or viral vector.

机构信息

Institute of Bioprocess Engineering and Pharmaceutical Technology, University of Applied Sciences Mittelhessen (THM), Giessen, Germany.

Department of Immunology, University of Tuebingen, Tuebingen, Germany.

出版信息

J Biotechnol. 2020 Nov 10;323:62-72. doi: 10.1016/j.jbiotec.2020.07.023. Epub 2020 Aug 5.

DOI:10.1016/j.jbiotec.2020.07.023
PMID:32763261
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7403136/
Abstract

In recent years, the Orf virus has become a promising tool for protective recombinant vaccines and oncolytic therapy. However, suitable methods for an Orf virus production, including up- and downstream, are very limited. The presented study focuses on downstream processing, describing the evaluation of different chromatographic unit operations. In this context, ion exchange-, pseudo-affinity- and steric exclusion chromatography were employed for the purification of the cell culture-derived Orf virus, aiming at a maximum in virus recovery and contaminant depletion. The most promising chromatographic methods for capturing the virus particles were the steric exclusion- or salt-tolerant anion exchange membrane chromatography, recovering 84 % and 86 % of the infectious virus. Combining the steric exclusion chromatography with a subsequent Capto™ Core 700 resin or hydrophobic interaction membrane chromatography as a secondary chromatographic step, overall virus recoveries of up to 76 % were achieved. Furthermore, a complete cellular protein removal and a host cell DNA depletion of up to 82 % was possible for the steric exclusion membranes and the Capto™ Core 700 combination. The study reveals a range of possible unit operations suited for the chromatographic purification of the cell culture-derived Orf virus, depending on the intended application, i.e. a human or veterinary use, and the required purity.

摘要

近年来,口疮病毒已成为保护性重组疫苗和溶瘤治疗的有前途的工具。然而,口疮病毒的生产方法(包括上下游)非常有限。本研究侧重于下游处理,描述了不同色谱单元操作的评估。在这方面,离子交换、拟亲和和排阻色谱被用于纯化细胞培养衍生的口疮病毒,旨在最大限度地提高病毒回收率和减少污染物。最有前途的用于捕获病毒颗粒的色谱方法是排阻或耐盐阴离子交换膜色谱,可回收 84%和 86%的感染性病毒。将排阻色谱与随后的 Capto Core 700 树脂或疏水性相互作用膜色谱结合作为二级色谱步骤,可实现高达 76%的总病毒回收率。此外,对于排阻膜和 Capto Core 700 组合,可以实现高达 82%的完整细胞蛋白去除和宿主细胞 DNA 耗尽。该研究揭示了一系列可能的单元操作,适用于细胞培养衍生的口疮病毒的色谱纯化,具体取决于预期的应用,即人类或兽医用途,以及所需的纯度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d0/7403136/278fba34f798/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d0/7403136/b433d3b9500f/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d0/7403136/1bd79c22cf22/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d0/7403136/6bdebb27b5ce/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d0/7403136/9c8b366d7c59/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d0/7403136/278fba34f798/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d0/7403136/b433d3b9500f/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d0/7403136/1bd79c22cf22/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d0/7403136/6bdebb27b5ce/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d0/7403136/9c8b366d7c59/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52d0/7403136/278fba34f798/gr5_lrg.jpg

相似文献

1
Selection of chromatographic methods for the purification of cell culture-derived Orf virus for its application as a vaccine or viral vector.用于从细胞培养物中纯化口疮病毒(Orf virus)以将其用作疫苗或病毒载体的色谱方法选择。
J Biotechnol. 2020 Nov 10;323:62-72. doi: 10.1016/j.jbiotec.2020.07.023. Epub 2020 Aug 5.
2
A scalable downstream process for the purification of the cell culture-derived Orf virus for human or veterinary applications.一种可扩展的下游工艺,用于纯化细胞培养来源的 Orf 病毒,用于人类或兽医应用。
J Biotechnol. 2020 Nov 10;323:221-230. doi: 10.1016/j.jbiotec.2020.08.014. Epub 2020 Aug 27.
3
A membrane-based purification process for cell culture-derived influenza A virus.一种用于细胞培养衍生甲型流感病毒的基于膜的纯化工艺。
J Biotechnol. 2016 Feb 20;220:12-20. doi: 10.1016/j.jbiotec.2015.12.022. Epub 2015 Dec 19.
4
Purification of yellow fever virus produced in Vero cells for inactivated vaccine manufacture.黄热病毒在 Vero 细胞中的纯化用于灭活疫苗的生产。
Vaccine. 2019 May 27;37(24):3214-3220. doi: 10.1016/j.vaccine.2019.04.077. Epub 2019 Apr 30.
5
Scalable chromatography-based purification of virus-like particle carrier for epitope based influenza A vaccine produced in Escherichia coli.基于色谱法的可扩展纯化方法,用于纯化在大肠杆菌中生产的基于表位的甲型流感疫苗的病毒样颗粒载体。
J Virol Methods. 2016 Jun;232:8-11. doi: 10.1016/j.jviromet.2016.02.011. Epub 2016 Mar 4.
6
Hydrophobic-interaction chromatography for purification of influenza A and B virus.疏水性相互作用色谱法用于纯化甲型和乙型流感病毒。
J Chromatogr B Analyt Technol Biomed Life Sci. 2019 Jun 1;1117:103-117. doi: 10.1016/j.jchromb.2019.03.037. Epub 2019 Apr 1.
7
Comparison of sample preparation techniques for the physicochemical characterization of Orf virus particles.比较用于 Orf 病毒粒子理化特性分析的样品制备技术。
J Virol Methods. 2022 Dec;310:114614. doi: 10.1016/j.jviromet.2022.114614. Epub 2022 Sep 6.
8
Generation and Selection of Orf Virus (ORFV) Recombinants.羊口疮病毒(ORFV)重组体的产生与筛选
Methods Mol Biol. 2016;1349:177-200. doi: 10.1007/978-1-4939-3008-1_12.
9
Steric exclusion chromatography for purification of cell culture-derived influenza A virus using regenerated cellulose membranes and polyethylene glycol.使用再生纤维素膜和聚乙二醇通过空间排阻色谱法纯化细胞培养衍生的甲型流感病毒
J Chromatogr A. 2017 Feb 3;1483:110-119. doi: 10.1016/j.chroma.2016.12.076. Epub 2016 Dec 29.
10
Capturing of cell culture-derived modified Vaccinia Ankara virus by ion exchange and pseudo-affinity membrane adsorbers.用离子交换和拟亲和膜吸附剂捕获细胞培养衍生的改良安卡拉痘苗病毒。
Biotechnol Bioeng. 2010 Mar 1;105(4):761-9. doi: 10.1002/bit.22595.

引用本文的文献

1
Navigating the Purification Process: Maintaining the Integrity of Replication-Competent Enveloped Viruses.探索纯化过程:维持有复制能力的包膜病毒的完整性
Vaccines (Basel). 2025 Apr 23;13(5):444. doi: 10.3390/vaccines13050444.
2
Advancing ORFV-Based Therapeutics to the Clinical Stage.将基于羊口疮病毒的疗法推进到临床阶段。
Rev Med Virol. 2025 May;35(3):e70038. doi: 10.1002/rmv.70038.
3
Efficient and scalable clarification of Orf virus from HEK suspension for vaccine development.从人胚肾细胞悬浮液中高效且可扩展地纯化口疮病毒用于疫苗开发。

本文引用的文献

1
Optimization of cell culture-derived influenza A virus particles purification using sulfated cellulose membrane adsorbers.使用硫酸化纤维素膜吸附剂优化细胞培养衍生的甲型流感病毒颗粒的纯化
Eng Life Sci. 2017 Oct 16;18(1):29-39. doi: 10.1002/elsc.201700108. eCollection 2018 Jan.
2
Heparin Mimic Material Derived from Cellulose Nanocrystals.源自纤维素纳米晶体的肝素模拟材料。
Biomacromolecules. 2020 Mar 9;21(3):1103-1111. doi: 10.1021/acs.biomac.9b01460. Epub 2020 Feb 14.
3
Immune Responses to Viral Gene Therapy Vectors.病毒基因治疗载体的免疫反应。
Vaccine X. 2024 Mar 13;18:100474. doi: 10.1016/j.jvacx.2024.100474. eCollection 2024 Jun.
4
Enhanced Downstream Processing for a Cell-Based Avian Influenza (H5N1) Vaccine.基于细胞的禽流感(H5N1)疫苗的强化下游加工
Vaccines (Basel). 2024 Jan 29;12(2):138. doi: 10.3390/vaccines12020138.
5
Impact of the Membrane Structure of the Stationary Phase on Steric Exclusion Chromatography (SXC) of Lentiviral Vectors.固定相膜结构对慢病毒载体空间排阻色谱(SXC)的影响。
Membranes (Basel). 2023 Oct 23;13(10):849. doi: 10.3390/membranes13100849.
6
Affinity and Pseudo-Affinity Membrane Chromatography for Viral Vector and Vaccine Purifications: A Review.用于病毒载体和疫苗纯化的亲和与假亲和膜色谱法综述
Membranes (Basel). 2023 Aug 30;13(9):770. doi: 10.3390/membranes13090770.
7
Evaluation of restricted access media for the purification of cell culture-derived Orf viruses.用于纯化细胞培养源的口疮病毒的受限访问介质的评估。
Eng Life Sci. 2023 Jul 14;23(9):e2300009. doi: 10.1002/elsc.202300009. eCollection 2023 Sep.
8
Evaluating Novel Quantification Methods for Infectious Baculoviruses.评估新型传染性杆状病毒定量方法。
Viruses. 2023 Apr 19;15(4):998. doi: 10.3390/v15040998.
9
Scaling Up of Steric Exclusion Membrane Chromatography for Lentiviral Vector Purification.扩大用于慢病毒载体纯化的空间排阻膜色谱法规模
Membranes (Basel). 2023 Jan 24;13(2):149. doi: 10.3390/membranes13020149.
10
A Summary of Practical Considerations for the Application of the Steric Exclusion Chromatography for the Purification of the Orf Viral Vector.用于纯化口疮病毒载体的空间排阻色谱法应用的实际考量总结
Membranes (Basel). 2022 Oct 29;12(11):1070. doi: 10.3390/membranes12111070.
Mol Ther. 2020 Mar 4;28(3):709-722. doi: 10.1016/j.ymthe.2020.01.001. Epub 2020 Jan 10.
4
Membrane-based steric exclusion chromatography for the purification of a recombinant baculovirus and its application for cell therapy.基于膜的空间排阻色谱法用于重组杆状病毒的纯化及其在细胞治疗中的应用。
J Virol Methods. 2020 Jan;275:113756. doi: 10.1016/j.jviromet.2019.113756. Epub 2019 Oct 20.
5
Hydrophobic-interaction chromatography for purification of influenza A and B virus.疏水性相互作用色谱法用于纯化甲型和乙型流感病毒。
J Chromatogr B Analyt Technol Biomed Life Sci. 2019 Jun 1;1117:103-117. doi: 10.1016/j.jchromb.2019.03.037. Epub 2019 Apr 1.
6
Orf virus: A promising new therapeutic agent.口疮病毒:一种有前景的新型治疗药物。
Rev Med Virol. 2019 Jan;29(1):e2013. doi: 10.1002/rmv.2013. Epub 2018 Oct 28.
7
Physical Characterization and Stabilization of a Lentiviral Vector Against Adsorption and Freeze-Thaw.抗吸附和冻融的慢病毒载体的物理特性分析及稳定性研究
J Pharm Sci. 2018 Nov;107(11):2764-2774. doi: 10.1016/j.xphs.2018.07.010. Epub 2018 Jul 12.
8
Purification of influenza virus-like particles using sulfated cellulose membrane adsorbers.使用硫酸化纤维素膜吸附剂纯化流感病毒样颗粒。
J Chem Technol Biotechnol. 2018 Jul;93(7):1988-1996. doi: 10.1002/jctb.5474. Epub 2017 Dec 16.
9
Novel oncolytic chimeric orthopoxvirus causes regression of pancreatic cancer xenografts and exhibits abscopal effect at a single low dose.新型溶瘤嵌合正痘病毒在单次低剂量下即可使胰腺癌异种移植物消退,并产生远隔效应。
J Transl Med. 2018 Apr 26;16(1):110. doi: 10.1186/s12967-018-1483-x.
10
Inactivated Orf-virus shows disease modifying antiviral activity in a guinea pig model of genital herpesvirus infection.灭活的口疮病毒在生殖器疱疹病毒感染的豚鼠模型中显示出具有疾病修饰的抗病毒活性。
J Microbiol Immunol Infect. 2018 Oct;51(5):587-592. doi: 10.1016/j.jmii.2017.03.002. Epub 2017 Jun 27.